Swedish Orphan Biovitrum AB (publ) reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was SEK 4,925 million compared to SEK 3,661 million a year ago. Net income was SEK 543 million compared to SEK 696 million a year ago. Basic earnings per share from continuing operations was SEK 1.84 compared to SEK 2.36 a year ago. Diluted earnings per share from continuing operations was SEK 1.83 compared to SEK 2.33 a year ago.